about
Activation of invariant NKT cells exacerbates experimental visceral leishmaniasisFunctional Reconstitution of Natural Killer Cells in Allogeneic Hematopoietic Stem Cell TransplantationCytokines in Graft-versus-Host DiseaseA role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria.Common strategies to prevent and modulate experimental cerebral malaria in mouse strains with different susceptibilities.Critical roles for LIGHT and its receptors in generating T cell-mediated immunity during Leishmania donovani infectionVCAM-1 and VLA-4 modulate dendritic cell IL-12p40 production in experimental visceral leishmaniasis.Modification of T cell responses by stem cell mobilization requires direct signaling of the T cell by G-CSF and IL-10Type I IFN signaling in CD8- DCs impairs Th1-dependent malaria immunity.Allergen-encoding bone marrow transfer inactivates allergic T cell responses, alleviating airway inflammation.Lung parenchyma-derived IL-6 promotes IL-17A-dependent acute lung injury after allogeneic stem cell transplantationCD4+ natural regulatory T cells prevent experimental cerebral malaria via CTLA-4 when expanded in vivoIncreased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliteransAn activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition.IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.Innate immunity defines the capacity of antiviral T cells to limit persistent infectionIL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasis.SOCS3 regulates graft-versus-host disease.NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs.Reduced mucosal associated invariant T-cells are associated with increased disease severity and Pseudomonas aeruginosa infection in cystic fibrosis.CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease.CD8α+ DCs can be induced in the absence of transcription factors Id2, Nfil3, and Batf3.Identification and expansion of highly suppressive CD8(+)FoxP3(+) regulatory T cells after experimental allogeneic bone marrow transplantation.Telomerase inhibition effectively targets mouse and human AML stem cells and delays relapse following chemotherapy.Ibrutinib treatment ameliorates murine chronic graft-versus-host disease.NK cells require IL-28R for optimal in vivo activityTargeting Syk-activated B cells in murine and human chronic graft-versus-host disease.Blimp-1-Dependent IL-10 Production by Tr1 Cells Regulates TNF-Mediated Tissue Pathology.Donor colonic CD103+ dendritic cells determine the severity of acute graft-versus-host disease.Recent insights to the mechanisms of graft-versus-host disease.IFNAR1-Signalling Obstructs ICOS-mediated Humoral Immunity during Non-lethal Blood-Stage Plasmodium Infection.Acute graft-versus-host disease is regulated by an IL-17-sensitive microbiome.Stem cell mobilization with G-CSF analogs: a rational approach to separate GVHD and GVL?Advances in the understanding of acute graft-versus-host disease.Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia veraTargeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism.Mouse models of bone marrow transplantationClinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV® assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complicationsInvariant natural killer T cell-natural killer cell interactions dictate transplantation outcome after alpha-galactosylceramide administration.Autophagy-dependent regulatory T cells are critical for the control of graft-versus-host disease.
P50
Q27318814-50270DBA-D023-4020-804B-A26A8F96EB7FQ28069682-8AF0B674-AA5E-4C4D-981E-FAB3FB4E4CD1Q28082195-E61EDA9A-841B-4CCA-8F22-1C18FCE991C7Q30479825-4B053E95-FFF5-4D6E-B948-4AD627839C38Q30482595-4AE46083-18AC-42D4-BECD-36F4D7B5AB68Q31036509-2B28B0D6-BBF0-44F4-BE14-3F3441DF4386Q33370533-43EF7607-73D7-40D2-AE80-8643D089B91AQ33599208-20964988-BE89-437D-9DD9-17A6BD970CFEQ33685904-85933C8E-7C1D-4C95-86C7-5A64897AE363Q33752348-B73843BA-65D6-4C7D-B421-C7E3C6DAA1DCQ33758318-4877AABA-7E20-4771-AA81-FA7EEF6C982CQ33775493-F50EAE38-3334-4134-AADB-AF4BC853EC45Q33781179-44AA6C4C-3289-4AF8-8EF3-28EBF00051E7Q33798102-AE74BB5A-C149-4F83-85BF-4733C3C7D537Q33853636-1348DE20-E950-47ED-BB9D-56FE311ABE7EQ33902354-FA988A1D-D74E-4EB7-B60E-3890C47C1108Q33929197-D32B4023-206D-476B-B2E5-CAE025381A83Q34022451-41A51462-5233-494A-B924-E1CBBE4584B9Q34078681-E8F3E096-9041-4348-B11B-726D99F1ECC0Q34309058-F9ABA2D9-45EE-4166-B77C-DB193CD8AB8DQ34311645-EEB6094B-9F8A-4231-A1D0-6ABA89BCA965Q34321343-8BCD5037-2DCF-4532-92D1-59329549BF2DQ34637842-2FF9E407-61D9-4C0F-A957-31F1E688D2BAQ35049985-08F3647D-E907-4136-8ED1-811D8C18909AQ35140097-900A9D8F-BEF0-4A7F-A097-26C32D9A5033Q35590214-39E6C9EF-E583-4591-9063-D44A275F837EQ35784522-8426770B-7F41-46B7-B5C0-6E3769509DE6Q35893711-C63EAF08-0D29-4904-B981-EA648CF9D461Q35894369-1C331AF4-0F95-408D-A5B0-700399F378DCQ36178015-34432AB5-8046-48AE-A1BE-F6D049423220Q36182425-72E4E368-6A86-46B1-8DDB-13A9E8D3A4F4Q36264301-D0E6014E-15C4-45A0-97EA-7DDF8FCC6761Q36354616-B1422528-3D7E-4F33-9C36-A06CF38689EBQ36759581-C501BAF4-C7BB-4666-B864-BF36B5757504Q36814639-946A0D02-0EBE-42DC-B5A4-B0235D13B323Q36814639-C83EBEB4-9CA0-4A1A-96F3-BE25E6ABFCAAQ36851405-3CC0C01E-21C3-4C50-83A4-71C2BEC0250EQ37045969-21AA1461-EA75-415F-AE71-58166EDEAE6BQ37227240-181BC865-053D-45FB-9FC7-CF4E0D40B8B6Q37237496-DBB75716-A7E6-4514-9589-E683AF86E9BD
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Geoffrey R Hill
@ast
Geoffrey R Hill
@en
Geoffrey R Hill
@es
Geoffrey R Hill
@nl
Geoffrey R Hill
@sl
type
label
Geoffrey R Hill
@ast
Geoffrey R Hill
@en
Geoffrey R Hill
@es
Geoffrey R Hill
@nl
Geoffrey R Hill
@sl
altLabel
G.R. Hill
@en
Geoff Hill
@en
Geoffrey R Hill
@en
prefLabel
Geoffrey R Hill
@ast
Geoffrey R Hill
@en
Geoffrey R Hill
@es
Geoffrey R Hill
@nl
Geoffrey R Hill
@sl
P1053
O-2630-2016
P106
P21
P31
P3829
P496
0000-0003-2994-0429